Specific changes in faecal microbiota are associated with familial Mediterranean fever. Issue 10 (October 2019)

• Record Type: Journal Article
• Authors: Deshayes, Samuel; Fellahi, Soraya; Bastard, Jean-Philippe; Launay, Jean-Marie; Callebert, Jacques; Fraisse, Thibault; Buob, David; Boffa, Jean-Jacques; Giurgea, Irina; Dupont, Charlotte; Jegou, Sarah; Straube, Marjolène; Karras, Alexandre; Aouba, Achille; Grateau, Gilles; Sokol, Harry; Georgin-Lavialle, Sophie
• Other Names: author non-byline.; Amselem Serge author non-byline.; Louvrier Camille author non-byline.; Savey Léa author non-byline.; Galland Joris author non-byline.; Hankard Antoine author non-byline.; Cez Alexandre author non-byline.; Michel Pierre-Antoine author non-byline.; Knebelmann Bertrand author non-byline.; Hertig Alexandre author non-byline.; Isnard Bagnis Corinne author non-byline.; Belenfant Xavier author non-byline.; Martin Silva Nicolas author non-byline.; Saadoun David author non-byline.; Legris Tristan author non-byline.
• Is Part Of: Annals of the rheumatic diseases. Volume 78:Issue 10(2019)
• Page Start: 1398
• Publication Date: 2019-10
• Subjects: familial Mediterranean fever -- AA amyloidosis -- microbiota -- adipokines -- indoleamine 2, 3-dioxygenase; Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2019-215258
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Objectives: Familial Mediterranean fever (FMF) can be complicated by AA amyloidosis (AAA), though it remains unclear why only some patients develop amyloidosis. We examined the gut microbiota composition and inflammatory markers in patients with FMF complicated or not by AAA. Methods: We analysed the gut microbiota of 34 patients with FMF without AAA, 7 patients with FMF with AAA, 19 patients with AAA of another origin, and 26 controls using 16S ribosomal RNA gene sequencing with the Illumina MiSeq platform. Associations between bacterial taxa and clinical phenotypes were evaluated using multivariate association with linear models statistical method. Blood levels of interleukin (IL)−1β, IL-6, tumour necrosis factor-α and adipokines were assessed by ELISA; indoleamine 2, 3-dioxygenase (IDO) activity was determined by high-performance liquid chromatography. Results: Compared with healthy subjects, specific changes in faecal microbiota were observed in FMF and AAA groups. Several operational taxonomic units (OTUs) were associated with FMF. Moreover, two OTUs were over-represented in FMF-related AAA compared with FMF without AAA. Additionally, higher adiponectin levels and IDO activity were observed in FMF-related AAA compared with FMF without AAA (p<0.05). Conclusion: The presence of specific changes in faecal microbiota in FMF and in FMF-related AAA suggests that intestinal microorganisms may play a role in the pathogenesis of these diseases. These findings may offer an opportunity to use techniques for gut microbiota manipulation.